A02. JA FAR Part 6 - Tissue Sealant--FINAL REDACTED.pdf

This document is a Justification and Approval (J&A) for a Federal Acquisition Regulation (FAR) Part 6 contract award for a Tissue Sealant. The contract was awarded to BRIDGE PTS, INCORPORATED on 2024-09-17 for $199,960.08 by the Defense Health Agency. The J&A provides the rationale for using a sole-source procurement method to acquire the Tissue Sealant product. Key details include the product description, the agency's requirement, the basis for the sole-source justification, and the expected performance period.